Paula Wróblewska-Łuczka

19PUBLICATIONS
29CO-AUTHORS
Molecular targetsChemotherapyCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 14, 2026
Biological activities and therapeutic potential of soy isoflavones: a focus on anticancer activity.

|Aug 14, 2025
Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin-In Vitro Isobolographic Studies.

Danuta Krasowska, Paula Wróblewska-Łuczka, Michał Chojnacki

|Feb 25, 2025
Screening of the Antimelanoma Activity of Monoterpenes-In Vitro Experiments on Four Human Melanoma Lines.

Paula Wróblewska-Łuczka, Laura Kulenty, Katarzyna Załuska-Ogryzek

|Nov 29, 2023
AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.

Paweł Marzęda, Paula Wróblewska-Łuczka, Magdalena Florek-Łuszczki

|Jul 29, 2023
Anticancer effect of terpenes: focus on malignant melanoma.

Paula Wróblewska-Łuczka, Justyna Cabaj, Julia Bargieł

|Jun 28, 2023
Daphnetin, a Coumarin with Anticancer Potential against Human Melanoma: In Vitro Study of Its Effective Combination with Selected Cytostatic Drugs.

Paula Wróblewska-Łuczka, Agnieszka Góralczyk, Jarogniew J Łuszczki

Pageof 4

Frequent Collaborators

17 joint publications

Jarogniew J Łuszczki

6 joint publications

Agnieszka Góralczyk

5 joint publications

Katarzyna Załuska-Ogryzek

3 joint publications

Magdalena Florek-Łuszczki